참고문헌 (52)

1. CA Cancer J Clin F Bray 68 6 394 2018 10.3322/caac.21492 Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. 

   상세보기

2. Lancet E Van Cutsem 388 10060 2654 2016 10.1016/S0140-6736(16)30354-3 Van Cutsem E, et al. Gastric cancer. Lancet. 2016;388(10060):2654-64. 

   상세보기

3. M Rugge 23 2015 Epidemiology of gastric cancer, in gastric cancer Rugge M, Fassan M, Graham DY. Epidemiology of gastric cancer, in gastric cancer. Cham: Springer; 2015. p. 23-34. 

4. Nat Rev Cancer Y Yuasa 3 8 592 2003 10.1038/nrc1141 Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003;3(8):592-600. 

   상세보기

5. Cancer Res P Correa 52 24 6735 1992 Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735-40. 

   상세보기

6. Lab Invest PH Schmidt 79 6 639 1999 Schmidt PH, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 1999;79(6):639-46. 

   상세보기

7. Nat Rev Drug Discov R Garzon 9 10 775 2010 10.1038/nrd3179 Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9(10):775-89. 

   상세보기

8. Trends Mol Med J Hayes 20 8 460 2014 10.1016/j.molmed.2014.06.005 Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460-9. 

   상세보기

9. Annu Rev Pathol YS Lee 4 199 2009 10.1146/annurev.pathol.4.110807.092222 Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199-227. 

   상세보기

10. Lancet Oncol T Ueda 11 2 136 2010 10.1016/S1470-2045(09)70343-2 Ueda T, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11(2):136-46. 

    상세보기

11. Gastroenterology. TS Han 156 4 1140 2018 10.1053/j.gastro.2018.11.059 Han TS, et al. Interleukin 1 Upregulates MicroRNA 135b to Promote Inflammation-associated Gastric Carcinogenesis in Mice. Gastroenterology. 2018;156(4):1140-55. 

    상세보기

12. Gastroenterology. Z Chen 156 4 1127 2018 10.1053/j.gastro.2018.11.052 Chen Z, et al. Integrated analysis of mouse and human gastric neoplasms identifies conserved microRNA networks in gastric carcinogenesis. Gastroenterology. 2018;156(4):1127-39. 

    상세보기

13. Gut JF Sousa 65 6 914 2016 10.1136/gutjnl-2014-308759 Sousa JF, et al. miR-30-HNF4gamma and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach. Gut. 2016;65(6):914-24. 

    상세보기

14. Sci Rep X Liu 7 1 7113 2017 10.1038/s41598-017-07193-w Liu X, et al. miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models. Sci Rep. 2017;7(1):7113. 

    상세보기

15. Nucleic Acids Res YK Kim 37 5 1672 2009 10.1093/nar/gkp002 Kim YK, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37(5):1672-81. 

    상세보기

16. Cancer Res Y Tsukamoto 70 6 2339 2010 10.1158/0008-5472.CAN-09-2777 Tsukamoto Y, et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010;70(6):2339-49. 

    상세보기

17. Proc Natl Acad Sci USA S Volinia 103 7 2257 2006 10.1073/pnas.0510565103 Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103(7):2257-61. 

    상세보기

18. Gut X Li 59 5 579 2010 10.1136/gut.2008.175497 Li X, et al. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59(5):579-85. 

    상세보기

19. Exp Ther Med X Du 15 1 599 2018 Du X, et al. miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy. Exp Ther Med. 2018;15(1):599-605. 

20. Med Sci Monit C Li 22 4509 2016 10.12659/MSM.898415 Li C, et al. MiR-30a decreases multidrug resistance (MDR) of gastric cancer cells. Med Sci Monit. 2016;22:4509. 

    상세보기

21. Exp Ther Med Y Liu 14 1 173 2017 10.3892/etm.2017.4477 Liu Y, et al. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor. Exp Ther Med. 2017;14(1):173-80. 

    상세보기

22. J Cell Mol Med Z Liu 18 4 610 2014 10.1111/jcmm.12209 Liu Z, et al. RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells. J Cell Mol Med. 2014;18(4):610-23. 

    상세보기

23. Eur Rev Med Pharmacol Sci LL Wang 20 9 1733 2016 Wang LL, et al. MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT). Eur Rev Med Pharmacol Sci. 2016;20(9):1733-9. 

24. Gastroenterology KT Nam 136 4 1288 2009 10.1053/j.gastro.2008.12.037 Nam KT, et al. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology. 2009;136(4):1288-96. 

    상세보기

25. Gastroenterology E Choi 150 4 918 2016 10.1053/j.gastro.2015.11.049 Choi E, et al. Expression of activated ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions. Gastroenterology. 2016;150(4):918-30 (e13). 

    상세보기

26. Gastroenterology JR Goldenring 138 7 2207 2010 10.1053/j.gastro.2010.04.023 Goldenring JR, et al. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology. 2010;138(7):2207-10 (2210 e1). 

    상세보기

27. Am J Physiol Gastrointest Liver Physiol S Nomura 288 2 G362 2005 10.1152/ajpgi.00160.2004 Nomura S, et al. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2005;288(2):G362-G375375. 

    상세보기

28. Gastroenterology. CP Petersen 146 7 1727 2014 10.1053/j.gastro.2014.02.007 Petersen CP, et al. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells. Gastroenterology. 2014;146(7):1727-38 (e8). 

    상세보기

29. Carcinogenesis WQ Li 32 3 406 2011 10.1093/carcin/bgq259 Li WQ, et al. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. Carcinogenesis. 2011;32(3):406-10. 

    상세보기

30. Gastroenterology K Ito 140 5 1536 2011 10.1053/j.gastro.2011.01.043 Ito K, et al. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology. 2011;140(5):1536-46 (e8). 

    상세보기

31. Biomed Pharmacother JM Cao 93 554 2017 10.1016/j.biopha.2017.06.084 Cao JM, et al. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1. Biomed Pharmacother. 2017;93:554-60. 

    상세보기

32. Mol Cancer Res W Jia 9 12 1732 2011 10.1158/1541-7786.MCR-11-0245 Jia W, et al. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. Mol Cancer Res. 2011;9(12):1732-45. 

    상세보기

33. J Pathol WT Liao 232 4 415 2014 10.1002/path.4309 Liao WT, et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J Pathol. 2014;232(4):415-27. 

    상세보기

34. Mol Cancer ZY Lin 16 1 48 2017 10.1186/s12943-017-0615-x Lin ZY, et al. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2017;16(1):48. 

    상세보기

35. Mol Cancer K Liu 16 1 62 2017 10.1186/s12943-017-0632-9 Liu K, et al. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Mol Cancer. 2017;16(1):62. 

    상세보기

36. World J Gastroenterol SB Tian 21 31 9337 2015 10.3748/wjg.v21.i31.9337 Tian SB, et al. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol. 2015;21(31):9337-47. 

    상세보기

37. Oncogene N Zhang 33 24 3119 2014 10.1038/onc.2013.286 Zhang N, et al. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene. 2014;33(24):3119-288. 

    상세보기

38. Am J Physiol Gastrointest Liver Physiol VG Weis 307 8 G777 2014 10.1152/ajpgi.00169.2014 Weis VG, et al. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach. Am J Physiol Gastrointest Liver Physiol. 2014;307(8):G777-G79292. 

    상세보기

39. Cell Mol Gastroenterol Hepatol T Shimizu 9 1 61 2020 10.1016/j.jcmgh.2019.08.008 Shimizu T, et al. Decrease in MiR-148a expression during initiation of chief cell transdifferentiation. Cell Mol Gastroenterol Hepatol. 2020;9(1):61-78. 

    상세보기

40. J Oncol LH Jiang 2018 5167829 2018 10.1155/2018/5167829 Jiang LH, Zhang HD, Tang JH. MiR-30a: a novel biomarker and potential therapeutic target for cancer. J Oncol. 2018;2018:5167829. 

    상세보기

41. Cell Physiol Biochem X Yang 41 4 1616 2017 10.1159/000471111 Yang X, Chen Y, Chen L. The versatile role of microRNA-30a in human cancer. Cell Physiol Biochem. 2017;41(4):1616-32. 

    상세보기

42. Int J Cancer R Kumarswamy 130 9 2044 2012 10.1002/ijc.26218 Kumarswamy R, et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer. 2012;130(9):2044-53. 

    상세보기

43. Cancer Res M Liu 75 21 4593 2015 10.1158/0008-5472.CAN-14-3735 Liu M, et al. Heterochromatin protein HP1gamma promotes colorectal cancer progression and is regulated by miR-30a. Cancer Res. 2015;75(21):4593-604. 

    상세보기

44. Adv Exp Med Biol A Madamanchi 819 41 2014 10.1007/978-94-017-9153-3_3 Madamanchi A, Santoro SA, Zutter MM. Alpha2beta1 Integrin. Adv Exp Med Biol. 2014;819:41-60. 

    상세보기

45. Semin Cancer Biol D Naci 35 145 2015 10.1016/j.semcancer.2015.08.004 Naci D, Vuori K, Aoudjit F. Alpha2beta1 integrin in cancer development and chemoresistance. Semin Cancer Biol. 2015;35:145-53. 

    상세보기

46. PLoS One T Tran 6 10 e26858 2011 10.1371/journal.pone.0026858 Tran T, et al. Loss of the alpha2beta1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro. PLoS One. 2011;6(10):e26858. 

    상세보기

47. Cancer Res L Patrawala 67 14 6796 2007 10.1158/0008-5472.CAN-07-0490 Patrawala L, et al. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res. 2007;67(14):6796-805. 

    상세보기

48. Br J Cancer SC Kirkland 101 2 320 2009 10.1038/sj.bjc.6605143 Kirkland SC. Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer. 2009;101(2):320-6. 

    상세보기

49. Exp Cell Res S Honore 285 1 59 2003 10.1016/S0014-4827(02)00038-1 Honore S, et al. Alpha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco-2): implication of NADPH oxidase-dependent production of ROS. Exp Cell Res. 2003;285(1):59-71. 

    상세보기

50. Curr Biol NR Paul 25 22 R1092 2015 10.1016/j.cub.2015.09.049 Paul NR, Jacquemet G, Caswell PT. Endocytic trafficking of integrins in cell migration. Curr Biol. 2015;25(22):R1092-R11051105. 

    상세보기

51. Int J Cell Biol S Shin 2012 516789 2012 10.1155/2012/516789 Shin S, Wolgamott L, Yoon SO. Integrin trafficking and tumor progression. Int J Cell Biol. 2012;2012:516789. 

    상세보기

52. Nat Rev Cancer H Hamidi 18 9 533 2018 10.1038/s41568-018-0038-z Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533-48. 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.